Assisted Reproduction Unit, Department of Obstetrics and Gynaecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Department of Obstetrics and Gynecology, Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, Hangzhou, China.
Front Endocrinol (Lausanne). 2021 Jul 19;12:708247. doi: 10.3389/fendo.2021.708247. eCollection 2021.
Does dual trigger in freeze-all fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles improve the cumulative live-birth outcome compared with human chorionic gonadotropin (hCG) trigger?
Dual trigger for final follicular maturation improves the cumulative pregnancy and live-birth rates compared with hCG trigger in freeze-all IVF/ICSI cycles.
Dual trigger could increase the numbers of oocytes and mature oocytes and improve pregnancy rates.
This retrospective cohort analysis included data from 4438 freeze-all IVF/ICSI cycles between January 2012 and December 2017.
PARTICIPANTS/MATERIALS SETTING METHODS: Women aged 20-49 years who underwent ovarian stimulation and oocyte retrieval for autologous IVF/ICSI with a freeze-all policy in our centre were enrolled. Data on number of oocytes retrieved, number of mature oocytes, clinical pregnancy rate, live-birth rate, cumulative pregnancy rate, and cumulative live-birth rate (CLBR) were assessed and compared between patients who underwent a dual trigger and hCG trigger. Multivariate logistic regression was performed to identify and adjust for factors known to independently affect the CLBR.
A total of 4438 IVF/ICSI cycles were analyzed, including 1445 cycles with single hCG trigger and 2993 cycles with dual trigger. The cumulative biochemical pregnancy rate (60.8% 68.1%, P<0.001; odds ratio (OR): 0.727; 95% confidence interval (CI): 0.638-0.828), cumulative clinical pregnancy rate (52.9% 58.5%, P<0.001; OR: 0.796; 95%CI: 0.701-0.903), and CLBR (44.3% 50.5%, P<0.001; OR: 0.781; 95%CI: 0.688-10.886) were all significantly lower in the hCG-trigger group compared with the dual-trigger group. The clinical pregnancy rate (48.2% 58.2%, P=0.002; OR: 0.829; 95%CI: 0.737-0.934) and embryo implantation rate (34.4% 38.9%, P<0.001; OR: 0.823; 95%CI: 0.750-0.903) in each transfer cycle were also significantly lower in the hCG-trigger group compared with the dual-trigger group. After controlling for all potential confounding variables, the trigger method was identified as an independent factor affecting the CLBR. The OR and 95%CI for hCG trigger were 0.780 and 0.641-0.949 (P=0.013).
The data used to analyse the effect of dual trigger on cumulative pregnancy and live-birth outcomes were retrospective, and the results may thus have been subject to inherent biases. Further prospective randomized controlled trials are required to verify the beneficial effects of dual trigger.
Dual trigger had a positive effect on CLBRs, suggesting that it could be used as a routine trigger method in freeze-all cycles.
STUDY FUNDING/COMPETING INTERESTS: This study was supported by grants from National Key Research and Development Program of China (2018YFC1004800), the Natural Science Program of Zhejiang (LY19H040009), the National Natural Science Foundation of China (No. 81601236). No authors have competing interests to declare.
与人绒毛膜促性腺激素(hCG)触发相比,冻融 试管婴儿/卵胞浆内单精子注射(ICSI)周期中的双重触发是否能改善累积活产结局?
与 hCG 触发相比,最终卵泡成熟的双重触发可提高冻融 IVF/ICSI 周期中的累积妊娠率和活产率。
双重触发可以增加卵母细胞和成熟卵母细胞的数量,并提高妊娠率。
研究设计、规模、持续时间:这是一项回顾性队列分析,纳入了 2012 年 1 月至 2017 年 12 月期间在我院进行的 4438 例冻融 IVF/ICSI 周期的数据。
参与者/材料设置方法:纳入年龄在 20-49 岁之间、接受自身 IVF/ICSI 卵巢刺激和取卵且采用冻融策略的患者。评估并比较了接受双重触发和 hCG 触发的患者的取卵数、成熟卵母细胞数、临床妊娠率、活产率、累积妊娠率和累积活产率(CLBR)。采用多变量逻辑回归来确定和调整已知独立影响 CLBR 的因素。
共分析了 4438 个 IVF/ICSI 周期,其中 1445 个周期接受单 hCG 触发,2993 个周期接受双重触发。累积生化妊娠率(60.8% vs. 68.1%,P<0.001;优势比(OR):0.727;95%置信区间(CI):0.638-0.828)、累积临床妊娠率(52.9% vs. 58.5%,P<0.001;OR:0.796;95%CI:0.701-0.903)和 CLBR(44.3% vs. 50.5%,P<0.001;OR:0.781;95%CI:0.688-10.886)在 hCG 触发组均显著低于双重触发组。在每个移植周期中,临床妊娠率(48.2% vs. 58.2%,P=0.002;OR:0.829;95%CI:0.737-0.934)和胚胎着床率(34.4% vs. 38.9%,P<0.001;OR:0.823;95%CI:0.750-0.903)也显著低于双重触发组。在控制所有潜在混杂变量后,触发方法被确定为影响 CLBR 的独立因素。hCG 触发的 OR 和 95%CI 分别为 0.780 和 0.641-0.949(P=0.013)。
局限性/谨慎理由:用于分析双重触发对累积妊娠和活产结局影响的数据为回顾性,因此结果可能存在固有偏倚。需要进一步的前瞻性随机对照试验来验证双重触发的有益效果。
双重触发对 CLBR 有积极影响,表明它可以作为冻融周期的常规触发方法。
研究资助/利益冲突:本研究得到了国家重点研发计划(2018YFC1004800)、浙江省自然科学基金(LY19H040009)和国家自然科学基金(No. 81601236)的支持。没有作者有利益冲突需要声明。